Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2021-01-12 2021-01-11
Drug Identification Number 02486636 02486636
Brand name SODIUM BICARBONATE INJECTION, USP SODIUM BICARBONATE INJECTION, USP
Common or Proper name Sodium Bicarbonate Injection Sodium Bicarbonate Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients SODIUM BICARBONATE SODIUM BICARBONATE
Strength(s) 84MG 84MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 8.4%, 50 mEq (mmol), 50 mL Vial 8.4%, 50 mEq (mmol), 50 mL Vial
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-11-30 2020-11-30
Actual start date
Estimated end date 2021-01-04 2021-01-04
Actual end date 2021-01-11 2021-01-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that our Sodium Bicarbonate Injection, USP 8.4% 50 mEq (mmol) Vial 50 mL will be available at Ontario distribution centers today, Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021. Fresenius Kabi Canada Ltd. is pleased to advise that our Sodium Bicarbonate Injection, USP 8.4% 50 mEq (mmol) Vial 50 mL will be available at Ontario distribution centers today, Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021.
Health Canada comments